MATTHEW GATLIN: Open Payments
NPI 1245552140 · SUPERIOR, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$194 in 12 payments from 7 companies in 2025. Trend: 2023 $465 · 2024 $862 · 2025 $194
Food & beverage: $194
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $44 |
| ABBVIE INC. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: REXULTI, Ozempic, VRAYLAR, Auvelity, CAPLYTA, MAVYRET, EVENITY.
Industry payments across NE — which companies pay providers there.
